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Background: Walking is recognized as an easily accessible mode of physical activity and is therefore supported as a
strategy to promote health and well-being. To complement walking, pedometers have been identified as a useful tool
for monitoring ambulatory physical activity, typically measuring total steps/day. There is, however, little information
concerning dose-response for health outcomes in relation to intensity or duration of sustained steps. We aimed to
examine this relationship, along with factors that mediate it, among employed adults.
Methods: A convenience sample, recruited from work-site health risk screening (N = 312, 37 ± 9 yrs), wore a pedometer
for at least three consecutive days. Steps were classified as “aerobic” (≥100 steps/minute and ≥10 consecutive minutes)
or “non-aerobic” (<100 steps/minute and/or <10 consecutive minutes). The data were sub-grouped according to
intensity-based categories i.e. “no aerobic activity”, “low aerobic activity” (1-20 minutes/day of aerobic activity) and “high
aerobic activity” (≥21 minutes/day of aerobic activity), with the latter used as a proxy for current PA guidelines (150-minutes
of moderate-intensity PA per week). Health outcomes included blood pressure, body mass index, percentage body fat,
waist circumference, blood cholesterol and blood glucose. Analysis of covariance, adjusting for age, gender and total steps/
day were used to compare groups according to volume and intensity-based steps categories. A further analysis compared
the mediation effect of body fat estimates (percentage body fat, body mass index and waist circumference) on
the association between steps and health outcomes, independently.
Results: Average steps/day were 6,574 ± 3,541; total steps/day were inversely associated with most health outcomes in
the expected direction (p < 0.05). The “no aerobic activity” group was significantly different from the “low aerobic
activity” and “high aerobic activity” in percentage body fat and diastolic blood pressure only (P < 0.05). Percentage body
fat emerged as the strongest mediator of the relationship between steps and outcomes, while body mass index
showed the least mediation effect.
Conclusion: The study provides a presentation of cross-sectional pedometer data that relate to a combination of intensity
and volume-based steps/day and its relationship to current guidelines. The integration of volume, intensity and duration
of ambulatory physical activity in pedometer-based messages is of emerging relevance.* Correspondence: pillayjd@dut.ac.za
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The association between physical inactivity and the in-
creased risk of many clinical conditions has been well
documented and is currently a major global public
health concern [1,2]. Data from longitudinal cohort
studies indicate at least a 1.5 to 2.0-fold higher risk of
most chronic diseases of lifestyle with physical inactivity,
such as coronary heart disease, type-2 diabetes, and
hypertension [3-5].
The World Health Organization (WHO) physical activ-
ity guidelines recommend that individuals accumulate at
least 150 minutes of moderate intensity physical activity
(PA) per week (or equivalent), in bouts of at least 10 con-
secutive minutes in duration [6]. Such a recommendation
is identified to result in a reduction in risk for all-cause
mortality and disease-specific morbidity and mortality [6].
This dose-response effect encompasses components of PA
including: mode, intensity, duration and frequency, and the
expected response of improved health and well-being [7,8].
Walking has been reported as the most common
mode of PA in both developed and developing countries
[7,9-12]. This is, in part, due to the fact that walking is
an inexpensive and easily accessible activity for a large
portion of the general population [10] and across age
groups [7]. Furthermore, there are fewer physical, social
and psychological barriers associated with walking than
with other forms of exercise [13].
Walking has been promoted, in part, by the growing
popularity of pedometers and pedometer-linked health
promotion messages, believed to be of Japanese origin
and dating as far back as the 1960’s, that have suggested
10,000 steps per day (steps/day) as a target for health
benefits [14-16].
A systematic review of 32 empirical studies suggests
that relatively healthy adults take between 7,000-13,000
steps/day [17]. Tudor-Locke and Myers [18] have, how-
ever, suggested that 10,000 steps/day is unrealistically
high for low-active or inactive adults and may therefore
contribute to low program adherence. Furthermore,
studies on the extent to which walking contributes to
meeting PA guidelines, have generally presented
volume-based steps/day information with limited infor-
mation on the intensity of steps [19-21].
In the context of walking and steps/day recommendations,
recent studies have been directed towards the application of
intensity-based steps, such as a steps/minute rate for moder-
ate intensity PA. For example, studies have shown that
30 minutes of moderate-to-vigorous walking equates to
between 3,100 and 4,000 steps [22-24], even when con-
sidering factors such as stride length and body mass
index in their recommendations [24,25]. Such studies
have accordingly emphasized the significance of intensity-
based steps/day recommendations as an emerging area of
research. Further to this, recent studies make reference tointensity-based step recommendations and, in particular,
an appropriate steps/minute rate for moderate intensity
PA [23-25].
Information on ambulatory PA patterns, in the context
of steps/day and, particularly, intensity-based steps which
will add to the current understanding of the dose-response
effects of walking. Such an application will support the use
of intensity-based steps/day recommendations as an
additional strategy/option for attaining current PA
guidelines.
The aim of this study was, therefore, to determine the as-
sociation between the volume and intensity of daily steps
accumulated, and health measures in a South African
employed adult group. The study also explores the extent
to which body composition (percentage body fat, body
mass index and waist circumference) may mediate the asso-
ciation between steps/day and clinical outcomes (blood
pressure, blood cholesterol and blood glucose).
Methods
The study was a cross-sectional study among South African
employed adults.
Participant recruitment
A convenience sample of participants was recruited
through an invitation email sent out to employees, or
following the completion of a health risk screening
hosted at corporate organizations or private health facil-
ities. The corporate organizations mainly comprised
health insured, white-collared workers. The range of
work performed by the employees varied considerably
(from secretarial/administrative to senior management
roles). The physical activity levels required by, and per-
formed in most of these jobs were low in general. Upon
completion of the informed consent form, participants
were provided with a blinded pedometer.
Pedometer wear
Participants were requested to wear an Omron HJ 720
ITC pedometer, attached to the left or right hip, as worn
in most studies [26]. A 5-consecutive-day protocol was
decided on as the number of days the participants would
be requested to wear the pedometer. This would in-
crease probability of obtaining at least three consecutive
days of pedometer data, as a minimum criterion for esti-
mating daily ambulatory PA [27-29].
The pedometer screen was covered to reduce the like-
lihood of participants observing their daily steps, which
may have influenced habitual levels of PA and subse-
quently, daily steps accumulation during the study. Par-
ticipants were asked to wear the pedometer throughout
the day, to follow their usual routine of daily activities
and to remove the pedometer only when bathing, show-
ering or sleeping.
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would be made available to them at the end of the study.
Inclusion and exclusion criteria
Employees attending the health screening event and/or
willing to participate in the study were eligible for inclu-
sion. Other criteria included: being between the age of
21 years (inclusive) and 50 years (exclusive) and; willingness
to wear a blinded pedometer, during waking hours, for the
duration of the study.
Employees were excluded for the following reasons:
pregnancy; diagnosis or treatment of cancer; any other
condition that could impact PA; non-compliance to the
pedometer wear and; participating in non-ambulatory
PA (such as swimming and cycling) that may not be cap-
tured or may be inaccurate through the pedometer
reading.
Ethical considerations and informed consent
The study was approved by the Faculty of Health Sciences
Research Ethics Committee (REC REF: 348/2008) of the
University of Cape Town. Permission was also obtained
from the corporate organizations to provide an on-site
health screening event and invite employees to participate
in the study. Employees were provided with a Participant
Information Sheet, at the health screening event, detailing
the purpose, aims, procedures, requirements and potential
risks of the study. Thereafter, they were required to sign
an Informed Consent Form.
Body measures
Anthropometric measures were completed by a trained
researcher/student as part of the health screening event.
Body height was measured in centimeters, using a
height chart as the vertical distance from the floor to the
vertex of the head. The participants stood barefoot with
arms at their sides, and heels, buttocks and head in con-
tact with the wall.
Waist circumference was measured (in centimeters)
using a tape measure around the skin of the waist at the
level of the umbilicus.
Body weight was measured using an electronic scale
(Beurer® PS 06), allowing only a single layer of clothing.
The values were rounded to the nearest 0.1 kg.
Body mass index was computed as weight (in kg) di-
vided by height (in meters) squared.
The Omron Body Composition Monitor (BF500),
which is based on the principles of bioelectrical imped-
ance, was used to measure percentage body fat [30].
Blood pressure (BP) was recorded (in mmHg) using an
electronic sphygmomanometer after the participant
remained relaxed for five minutes. Two readings were
taken, approximately five minutes apart. An average of
the two readings was recorded. If the two readingsobtained were different from each other (>5 mmHg), a
third reading was taken. The average of the two nearest
readings was used.
Finger prick blood cholesterol and blood glucose were
taken using the Accutrend Plus® monitor device and
measured in mmol/L.
The Omron HJ 720 ITC pedometer
The Omron HJ 720 ITC (Omron Corp., Kyoto, Japan) is
an example of a piezoelectric pedometer that provides
information on intensity of steps taken, including a
memory function that recalls previous data. The validity
and reliability of this brand and model of pedometer has
been studied at various mounting positions under pre-
scribed and self-paced walking conditions with both
healthy and overweight adults [31,32]. Such studies have
promoted its application as an accurate measure of step
counts [31,32].
A valuable feature of the pedometer is that the infor-
mation captured by the pedometer can be uploaded
electronically. The electronic display presents informa-
tion as a visual display (bar graph) and further includes
a 43 day recall with the ability to summarize information
by weekly and monthly categories. A further benefit of
this brand of pedometer is its ability to provide an
hourly representation of steps data. The pedometer dis-
play differentiates hours that the pedometer was worn
(even if no steps were accumulated) from hours that the
pedometer was not worn.
Information provided on the pedometer display for im-
mediate viewing, includes daily steps information, such as
the total number of steps accumulated [33]. Additionally,
the number of “manufacturer-defined aerobic steps”
(>60 steps/minute, minimum duration of 1-minute),
duration (in minutes) of “manufacturer-defined aerobic
steps”, distance (in kilometers) completed and calories
(kilocalories) expended are displayed [33]. The “manu-
facturer-defined aerobic steps” within the total steps/
day record is therefore provided [33]. Consequently,
total time spent accumulating such steps (in minutes
per day (minutes/day)) is provided as aerobic time [33].
Data recording
The pedometer data were uploaded electronically by the
researcher according to the Omron Health Management
Manager Software Protocol [33]. Feedback on pedometer
data was communicated to the participant when the
pedometer was being returned. Participants were in-
cluded in the analyses if they had worn the pedometer
for a minimum of three consecutive days and for at least
ten hours on each of those days.
With particular reference to intensity-based steps, re-
cently documented literature on intensity-based steps/
day [23,34] suggests a minimum of 100 steps/minute to
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PA. Furthermore, the findings of recent pedometer-based
studies [35,36] make reference to 100 steps/minute as a
reliable indicator of moderate intensity PA.
Consequently, in our subsequent analysis, the 100
steps/minute rate for moderate intensity PA informed
the refinement of “manufacturer-defined aerobic steps”
to an estimate more relevant to current literature.
Current literature also recommends that the accumulation
of moderate intensity PA in bouts of at least ten minutes,
is acceptable in contributing towards meeting current PA
guidelines [6].
Thus, we limited our intensity-based analysis to bouts
of ten consecutive minutes or more and at a minimum
average intensity of 100 steps/minute, using the graphical
display of pedometer results. “Manufacturer-defined aer-
obic steps” were used as a basis for separating sustained
steps (≥60 steps/minute; duration ≥ 1 minute). This
category of steps was further stratified according to
whether these steps were sustained for at least ten minutes.
We then determined the average intensity of these bouts
(using the total number of steps and duration information).
Steps accumulated at a minimum average intensity of 100
steps/minute were categorized as “aerobic steps”.
The data were further sub-grouped according to
intensity-based categories i.e. “no aerobic activity”, “low
aerobic activity” (1-20 minutes/day of aerobic activity) and
“high aerobic activity” (≥21 minutes/day of aerobic activ-
ity). These sub-groups relate to current PA guidelines of
150 minutes of moderate intensity PA per week [6]. The
guideline of accumulating a minimum of 150 minutes per
week of moderate intensity PA [6-8] was translated to an
average daily approximation of 21 minutes.Mediator
Independent variable
a
c
Figure 1 Statistical mediation model.Mediation analysis
The mediation effect of percentage body fat, body mass
index and waist circumference on the association be-
tween both steps/day and aerobic time (as an estimate of
moderate intensity PA) on clinical outcomes (systolic
blood pressure, diastolic blood pressure, blood choles-
terol and blood glucose) was examined.
Our mediation analysis was informed by the product-of-
coefficient test, which essentially consisted of four steps
[37]. As a first step, we determined the total effect (c path)
of the independent variable (e.g. steps/day) on the out-
come variable (e.g. systolic blood pressure). We thereafter
determined the association between the independent vari-
able (e.g. steps/day) and the potential mediator (e.g. per-
centage body fat), calculated as the “a-coefficient”. Thirdly,
the association between the potential mediator and the
outcome variable was assessed (b-coefficient) and con-
trolled for the independent variable (c’ coefficient). Figure 1
illustrates these steps.The c-prime (c’) path is the direct ef-
fect of the independent variable on the outcome variable,
adjusted for the mediator. Finally, the mediated effects of
the independent variable on the outcome variable through
the proposed mediator, was determined by multiplying the
a- and b coefficient (a*b coefficient). We also calculated
the percentage mediation of the potential mediator (a*b/c)
to assess the percentage of the effect of the independent
variable on the outcome variable that could be explained
by the mediator.
Statistical analyses
The data were analyzed using STATISTICA version 8
(StatSoft Inc., Tulsa, OK, USA) and statistical signifi-
cance was set at P < 0.05. General characteristics of the variable
Dependent variable
b
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and additionally categorized by gender.
The data were subsequently grouped according to steps/
day and aerobic time categories, respectively. An analysis
of covariance (ANCOVA), adjusting for age, gender and
total steps/day (when analyzing intensity-based steps) was
used to compare groups based on volume and intensity-
based steps categories. A post-hoc Bonferroni test was
used to determine between group effects, where relevant.
For the mediation analysis, the bootstrapping statistical
approach, using 1,000 bootstrap re-samples, was used,
with the SPSS script of Preacher, Rucker and Hayes [38] to
calculate the bias corrected confidence intervals (ab paths)
around the mediated and direct associations [38].Results
Participant characteristics
Of the 366 participants who volunteered to participate
in the study, 312 participants (147 men and 165 women,
37 ± 9 yrs) wore the pedometer for a minimum of three
consecutive days, for at least ten hours for each of those
days, and were included in the analysis. Seventy-two par-
ticipants had completed pedometer wear for three con-
secutive days, 109 for four consecutive days and 131 for
five or more consecutive days. Eighty-nine participantsTable 1 General Characteristics of participants
Variable N Total
Age (years) 312 37.4 ± 9.3*
Height (m) 311 1.68 ± 0.1**
Weight (kg) 312 76.4 ± 16.8
Body mass
index (kg/m2)
304 26.9 ± 5.7*
% body fat (%) 244 30.0 ± 10.7**
Waist circumference
(cm)
302 85.8 ± 13.3
Systolic blood
pressure (mmHg)
296 120.9 ± 14.5
Diastolic blood
pressure (mmHg)
296 79.6 ± 11.7
Blood cholesterol
(mmol/L)
250 3.9 ± 1.1
Blood glucose
(mmol/L)
243 4.9 ± 1.8
Pedometer data
(total steps/day)
312 6,574 ± 3,541**
Average daily aerobic
steps (steps/day)
312 694 ± 1,465**
Average daily aerobic
time (minutes/day)
312 5.7 ± 12.0**
Note: Values are means ± standard deviation.
*indicates statistical significance (P < 0.05), **(P < 0.01) between men and women.had worn the pedometer for at least one weekend day
and 40 participants for both weekend days.
The mean (±SD) steps/day accumulated in men and
women was 7,476 ± 4,076 steps/day and 5,769 ± 2,759
steps/day, respectively.
Table 1 presents characteristics of the study group.
The data were subsequently grouped according to four
volume-based categories based on current steps/day
classifications [27,34]: “<5,000 steps/day”; “5,000-7,499
steps/day”; “7,500-9,999 steps/day” and “≥10,000 steps/
day” (Table 2).
A total of 112 participants (35.9%) accumulated an aver-
age of <5,000 steps/day, typically classified as inactive
[27,34]. Only 38 participants (12.2%) achieved an average
of ≥10,000 steps/day, typically classified as “active” [27,34].
Within the “active” group, most of the participants (73%)
also accumulated aerobic steps.
As illustrated in Table 2, the <5,000 steps/day group was
significantly different from all other groups (P < 0.05) in
percentage body fat, waist circumference and blood glu-
cose only, when adjusted for age, gender and daily aerobic
steps (so as to establish the independent effect of volume
of steps/day).
Table 3 presents our data according to intensity-based
categories, i.e. “no aerobic activity”; “low aerobic activity”
and “high aerobic activity”.n Men n Women
147 38.1 ± 9.9 165 36.8 ± 8.8
146 1.7 ± 0.1 165 1.6 ± 0.1
144 81.1 ± 15.2 165 72.2 ± 17.1
139 27.0 ± 4.9 165 26.8 ± 6.4
121 26.8 ± 8.8 123 33.2 ± 11.5
137 88.7 ± 12.1 165 83.4 ± 13.8
131 125.5 ± 13.3 165 117.3 ± 14.4
131 81.1 ± 12.0 165 78.4 ± 11.3
106 3.8 ± 0.9 144 4.0 ± 1.2
100 4.9 ± 1.4 143 4.9 ± 2.1
147 7,476 ± 4,076 165 5,769 ± 2,759
147 947 ± 1,771 165 468 ± 1,081
147 7.8 ± 14.6 165 3.8 ± 8.7
Table 2 Biometric and clinical measures by step per day categories
Variable N n <5,000 n 5,000-7,499 n 7,500-9,999 n ≥10,000
Weight (kg) 309 112 78.9 ± 19.0 99 75.4 ± 15.5 60 74.7 ± 17.2 38 73.8 ± 11.1
BMI (kg/m2) 304 110 28.1 ± 7.1 98 26.5 ± 5.1 59 25.7 ± 4.6 37 26.1 ± 3.6
% BF (%) 244 97 34.7 ± 12.5B 80 28.7 ± 8.3A 38 24.4 ± 7.2A 29 25.6 ± 7.7A
WC (cm) 302 111 89.9 ± 15.3B 99 84.8 ± 12.8A 56 81.3 ± 10.4A 36 83.0 ± 8.6A
SBP(mmHg) 296 111 122.2 ± 15.5 99 122.1 ± 15.0 55 117.9 ± 12.6 31 117.8 ± 11.1
DBP (mmHg) 296 111 81.9 ± 10.1 99 80.0 ± 13.1 55 76.1 ± 11.0 31 76.4 ± 11.5
BC (mmol/L) 250 99 4.1 ± 1.1 75 3.9 ± 1.2 47 3.7 ± 0.8 29 3.6 ± 0.8
BG(mmol/L) 243 98 5.4 ± 2.5B 71 4.5 ± 1.1A 45 4.4 ± 1.0A 29 4.8 ± 1.0A
Note: Values represent mean ± standard deviation, adjusted for age, gender and average daily aerobic steps.
Means with a different letter superscript indicate statistical significance between the groups compared (P < 0.05).
BMI- body mass index.
%BF- percentage body fat.
WC- waist circumference.
SBP- systolic blood pressure.
DBP- diastolic blood pressure.
BC- blood cholesterol.
BG- blood glucose.
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aerobic steps. Only 34 participants (11.0%) of the total
study group, however, accumulated aerobic steps for a
minimum duration of 21 minutes/day.
When adjusted for age, gender and total steps/day (to
establish the independent effect of intensity-based steps),
the “no aerobic activity” group was significantly different
from the “low aerobic activity” and the “high aerobic activ-
ity” in percentage body fat and diastolic blood pressure
only (P > 0.05). Table 3 illustrates these differences.
A subsequent analysis investigated the mediation effect
of variables related to body composition, i.e. percentage
body fat, body mass index and waist circumference, on the
association between volume and intensity-based steps/day
and clinical outcomes (systolic blood pressure, diastolic
blood pressure, blood cholesterol and blood glucose).Table 3 Biometric and clinical measures based on daily aerob
Variable N n No aerobic time
Weight (kg) 309 209 76.7 ± 17.5
BMI (kg/m2) 304 207 27.1 ± 6.1
% BF (%) 244 168 32.2 ± 11.6B
WC (cm) 302 207 86.9 ± 14.0
SBP(mmHg) 296 204 121.8 ± 15.0
DBP (mmHg) 296 204 80.9 ± 11.4B
BC (mmol/L) 250 183 4.0 ± 1.1
BG(mmol/L) 243 180 5.0 ± 2.1
Note: Values represent mean ± standard deviation, adjusted for age and gender and
Means with a different letter superscript indicate statistical significance between gr
BMI- body mass index.
%BF- percentage body fat.
WC- waist circumference.
SBP- systolic blood pressure.
DBP- diastolic blood pressure.
BC- blood cholesterol.
BG- blood glucose.Table 4 presents a summary of the results.
As indicated by the c path (direct effect), our results
clearly show that body composition mediates the associ-
ation between PA and health outcomes. However, as in-
dicated by the c’ path, the direct effect of nearly all the
outcome variables when adjusted for the mediator, was
no longer significant.
Percentage body fat was the strongest mediator (27-60%
mediation, in associations of statistical significance) in the
association between steps (steps/day and aerobic activity)
and clinical measures. Waist circumference also mediated
most of the associations between steps and clinical mea-
sures, although providing a weaker extent of mediation
(23-52% mediation, in associations of statistical signifi-
cance) than percentage body fat. Body mass index was evi-
dently a less convincing mediator in the associationsic step time categories
n 1-21 minutes/day n ≥21 minutes/day
66 76.8 ± 15.4 34 73.6 ± 15.2
63 26.9 ± 5.1 34 25.6 ± 4.6
49 26.2 ± 6.6A 27 23.7 ± 5.7A
63 84.0 ± 11.9 32 82.5 ± 10.6
60 119.4 ± 12.7 32 118.4 ± 13.9
60 77.4 ± 10.9A 32 75.2 ± 13.3A
42 3.8 ± 0.9 25 3.7 ± 0.8
39 4.5 ± 0.9 24 4.7 ± 1.8
total steps/day.
oups (P < 0.05).
Table 4 Mediation effect of percentage body fat, body mass index and waist circumference on the association between total daily steps/aerobic time and
clinical measures
Mediator Independent
variable
Outcome
Variable
c path (SE) a path (SE) b path (SE) c’ path (SE) ab path (95%CI) % mediation
Percentage
body fat
Total steps
(steps/day)
SBP (mmHg)
(n = 233)
-2.70(0.94) -3.61(0.67) 0.33(0.94) -1.50(0.98) -1.19(-2.46;-0.53) 44
DBP(mmHg)
(n = 233)
-2.75(0.78) -3.61(0.67) 0.28(0.08) -1.76(0.81) -0.99(-1.63;-0.49) 36
BC (mmol/L)
(n = 195)
-0.18(0.08) -3.44(0.74) 0.02(0.01) -0.11(0.08) -0.07(-0.16;-0.0006) 38
BG (mmol/L)
(n = 189)
-0.31(0.14) -3.37(0.74) 0.04(0.01) -0.19(0.15) -0.13(-0.35;-0.24) 42
Aerobic time
(minutes/day)
SBP (mmHg)
(n = 233)
-3.71(1.37) -4.39(0.98) 0.34(0.09) -2.22(1.39) -1.48(-2.72;-0.70) 60
DBP (mmHg)
(n = 233)
-4.34(1.12v) -4.39(0.98) 0.27(0.07) -3.14(1.14) -1.19(-1.98;-0.67) 27
BC (mmol/L)
(n = 195)
-0.18(0.13) -4.00(1.17) 0.02(0.01) -0.09(0.13) -0.08(-0.19;-0.01) 44
BG (mmol/L)
(n = 189)
-0.30(0.23) -4.13(1.20) 0.04(0.01) -0.13(0.23) 0.17(-0.46;-0.04) 57
Body mass
index
Total steps
(steps/day)
SBP (mmHg)
(n = 290)
-2.38(0.84) -1.04(0.34) 0.60(0.14) -1.75(0.82) -0.63(-1.31;-0.20) 26
DBP(mmHg)
(n = 290)
-2.61(0.69) -1.04(0.34) 0.51(0.11) -2.08(0.68) -0.53(-0.95;-0.20) 20
BC (mmol/L)
(n = 247)
-0.16(0.07) -0.71(0.38) 0.01(0.01) -0.15(0.07) -0.009(-0.05;0.005) 06
BG (mmol/L)
(n = 240)
-0.27(0.12) -0.77(0.38) 0.07(0.02) -0.27(0.12) -0.05(-0.17;-0.007) 19
Aerobic time
(minutes/day)
SBP (mmHg)
(n = 290)
-2.81(1.17) -0.67(0.50) 0.63(0.14) -2.38(1.17) -0.43(-1.18;0.10) 15
DBP (mmHg)
(n = 290)
-3.40(0.10) -0.67(0.50) 0.54(0.11) -3.03(0.96) -0.36(-0.87;0.09) 11
BC (mmol/L)
(n = 247)
-0.12(0.11) -0.38(0.57) 0.02(0.01) -0.12(0.11) -0.01(-0.05;0.01) 08
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Table 4 Mediation effect of percentage body fat, body mass index and waist circumference on the association between total daily steps/aerobic time and
clinical measures (Continued)
BG (mmol/L)
(n = 240)
-0.25(-0.18) -0.37(0.60) 0.07(0.02) -0.22(0.18) -0.03(-0.14;0.04) 12
Mediator Independent
variable
Outcome
Variable
c path (SE) a path (SE) b path (SE) c’ path (SE) ab path (95% CI) % mediation
Waist
circumference
Total steps
(steps/day)
SBP (mmHg)
(n = 292)
-2.60(0.83) -3.91(0.76) 0.34(0.06) -1.26(0.82) -1.34(-2.21;-0.76) 52
DBP(mmHg)
(n = 292)
-2.90(0.67) -3.91(0.76) 0.27(0.05) -1.83(0.67) -1.05(-1.65;-0.60) 36
BC (mmol/L)
(n = 243)
-0.15(0.07) -3.43(0.83) 0.01(0.01) -0.12(0.07) -0.03(-0.09;0.001) 20
BG (mmol/L)
(n = 236)
-0.30(0.12) -3.34(0.84) 0.03(0.01) -0.20(0.12) -0.10(-0.19;-0.05) 33
Aerobic time
(minutes/day)
SBP (mmHg)
(n = 292)
-3.30(1.21) -3.24(1.14) 0.35(0.06) -2.15(1.16) -1.14(-2.07;-0.46) 35
DBP (mmHg)
(n = 292)
-3.91(0.99) -3.24(1.14) 0.28(0.05) -2.99(0.95) -0.91(-1.62;-0.36) 23
BC (mmol/L)
(n = 243)
-0.12(0.11) -3.01(1.31) 0.01(0.01) -0.01(0.11) -0.03(-0.10;-0.0002) 25
BG (mmol/L)
(n = 236)
-0.25(0.19) -3.31(1.33) 0.03(0.01) -0.14(0.19) -0.11(-0.24;-0.03) 44
c = total effect of the independent variables (i.e. steps/day and aerobic time) on the outcome variable (i.e SBP, DBP, BC, BG),
a = association between the independent variable (e.g. steps/day) and the potential mediator (e.g. percentage body fat).
b = association between the potential mediator and the outcome variable was assessed, controlled for the independent variable.
c’ = direct effect of the independent variable on the outcome variable was determined.
ab = indirect effects of the independent variable on the outcome variable through the proposed mediator.
% mediation = percentage mediation of the potential mediator (a*b/c).
SE: Standard error.
values represented in bold indicate significant associations.
SBP- systolic blood pressure.
DBP- diastolic blood pressure.
BC- blood cholesterol.
BG- blood glucose.
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tical significance was found).
Discussion
The mean (±SD) steps/day of 6,574 ± 3,541 suggests that
our sample group fell below the lower end of 7,000-13,000
steps/day for healthy, younger adults [17]. Our data were,
nevertheless, consistent with the previous observation that
individuals accumulating <5,000 steps/day are more likely
to be classified as obese [39]. Significant differences were
also found between some biometric (percentage body fat,
waist circumference) and clinical (blood glucose) out-
comes in those participants in the <5,000 steps/day cat-
egory, when compared with the other steps/day categories.
As recently confirmed [14], total daily values less than
5,000 steps/day may be an appropriate index for inactivity
and its associated risk with health consequences, such as
obesity.
Additional findings were that 102 participants (32.7%)
accumulated aerobic steps (≥100 steps/min for a minimum
duration of 10-minutes/day). Only 34 participants (11.0%),
however, accumulated aerobic steps for an average of at
least 21 minutes/day, as a proxy for current PA guidelines
that make reference to moderate intensity PA. This sug-
gests that only approximately one-third of our study group
accumulated some moderate intensity PA relevant to the
current PA in respect to ambulatory PA [6].
The most notable finding was that most participants
accumulating more than 10,000 steps/day were also ac-
cumulating “aerobic” steps. A direct and independent as-
sociation of intensity-based steps was, however, only
found in percentage body fat and diastolic blood pres-
sure. The contribution of intensity-based steps towards
achieving 10,000 steps/day however, highlights the value
of intensity-based steps as a contributor towards achieving
volume-based recommendations. Our research, therefore,
emphasizes and supports emerging literature that exer-
cise prescription and/or steps/day recommendations
be framed within the context of volume, intensity and
duration of intensity-based steps rather than volume
alone [35,36].
Recent studies have shown that 30 minutes of
moderate-to-vigorous walking corresponds to a total of
between 3,000 and 4,000 steps [22,27,34,40]. In support
of our additional findings, reference to 3,000 steps in
30 minutes was, therefore made as an overall guideline
that incorporates volume, duration and intensity of
steps/day. The use of 3,000 steps in 30 minutes is, how-
ever suggested as a heuristic value and taken over and
above habitual activity levels. This recommendation
therefore still supports the accumulation of volume-
based steps and the 10,000 steps/day recommendation.
Whilst our study group may not be truly representa-
tive of the South African adult population, the results dosupport the viewpoint that globally, most adults are cur-
rently not meeting PA guidelines [41].
Association between steps per day and body composition
Research has shown that people meeting the 10,000
steps/day target are more frequently classified as normal
weight and those individuals with values less than 5,000
steps/day are more frequently classified as obese [39]. In
addition, a distinct relationship between steps/day and
body composition variables in the expected direction
[39,42-47] has been previously reported.
In general, we did not find significant differences in
body composition between participants accumulating
more than 10,000 steps/day versus those accumulating
7,500-9,999 steps/day or even 5,000-7,499 steps/day.
There was, however, significance between the <5,000
steps/day group and the other three groups in percentage
body fat and waist circumference (adjusted for age, gender
and aerobic steps, so as to establish the true effect of vol-
ume of steps/day). Similarly, there was a significant differ-
ence between the “no aerobic time” group and the other
two groups in percentage body fat (adjusted for age, gender
and total steps/day, so as to establish the independent ef-
fect of intensity based steps), suggesting that “some”
intensity-based steps is better than “none”.
Steps per day in relation to moderate intensity physical
activity and current physical activity guidelines
The categorization of our pedometer data into intensity-
based steps categories described in the methodology so
as to relate to current PA guidelines, showed conflicting
findings. After adjusting for age, gender and total steps/
day (to establish the independent effect of intensity-
based steps), only percentage body fat and diastolic
blood pressure were significantly different between the
“no aerobic activity” and the “low aerobic activity” groups.
A similar finding was observed when comparisons be-
tween the “no aerobic activity” and the “high aerobic activ-
ity” groups were made. No other between-group effects
were noted. This may direct us to the notion that “some
physical activity is better than none” [45].
Furthermore, the observation that most people accu-
mulating 10,000 steps also accumulated intensity-based
steps directs us to the viewpoint that intensity-based
steps contributes to improved outcomes by increasing
total volume of steps/day.
Tudor-Locke et al, in a recent paper [14], identifies the
gap in current literature on the impact of intensity-
based walking programs and on clinical outcomes,
within the context of pedometry. Whilst pedometer-
based walking programs have shown increased walking
behavior and varying levels of improvement in clinical
outcomes, research on the impact of intensity-based
walking programs and their effect on clinical outcomes,
Pillay et al. BMC Public Health  (2015) 15:174 Page 10 of 12is of emerging importance. Our study, in exploring the
interplay between volume and intensity-based steps/day,
supports this recommendation.Mediation effect of waist circumference, percentage body
fat and body mass index in the association between steps
per day and clinical outcomes
Mediation analysis has emerged as a statistical tech-
nique for providing insights into the mechanisms of
change, particularly in behavioral interventions. As
such, in the area of PA and health, mediation analysis
has been used to determine which behaviors contrib-
ute to weight loss. The notion that regular physical ac-
tivity is associated with lower body fat composition
(body mass index, percentage body fat and waist cir-
cumference) and improved clinical measures is well
documented. Resting Energy Expenditure and the
variation thereof is, however, largely due to differences
in the extent of lean body mass and fat mass of an in-
dividual [48]. Consequently, all associations between
body size and other outcomes (such as cardiovascular
risk factors) are partially confounded by the associ-
ation with resting energy expenditure [48]. Increased
levels of PA are seen to increase energy expenditure
and improve clinical measures, such as reducing blood
pressure [48].
After accounting for PA, the positive correlation be-
tween increased resting energy expenditure and blood
pressure, for example [49] may direct us to the view-
point that the association between PA and clinical out-
comes might be mediated by factors relating to body fat.
From our mediation analysis, it is evident that the rela-
tionship between steps/day (both total steps/day and
aerobic time) and clinical outcomes (blood pressure,
blood cholesterol and blood glucose) were influenced
(mediated) by body composition estimates. In our study,
percentage body fat emerged as the strongest and signifi-
cant mediator in this association, and may, therefore be
a useful consideration in the associations between PA
measures and clinical outcomes, particularly as a criter-
ion measure for body composition.
Whilst our results have clearly shown that body com-
position mediates the association between PA and
health outcomes, the loss of significance of nearly all
the outcome variables when adjusted for the mediator,
further highlights that body composition (and most
notably, percentage body fat) “completely”, rather than
“partially”, mediates the association between PA and
health outcomes.
Although such a finding has valuable and far-reaching
implications on PA and health, the information pre-
sented may not, however, be able to draw inferences to
causality, due to the cross-sectional nature of the data.Strengths of the study
The research undertaken is, to our knowledge, among
the first pedometer-based studies conducted in the
Republic of South Africa, within an urban context,
that establishes the association between ambulatory
PA and health measures in an adult, employed population
group.
The study was useful in establishing associations be-
tween volume, intensity (in terms of aerobic steps/day
accumulated) and duration (total time spent in aerobic
activity) of ambulatory PA and health measures.
A number of studies that have directly measured mod-
erate intensity as 3 METs have concluded that 100
steps/minute is a reasonable heuristic value, indicative of
moderate intensity PA [14,34,50]. The application of the
100 steps/minute criterion within our data analyses pro-
vides a unique presentation of cross-sectional pedometer
data that relates to a combination of intensity and
volume-based steps/day rather than volume alone.
The study, by way of the mediation analysis, provides
an interesting finding on the role of physical activity in
improving health through improved body composition.
Limitations
The cross-sectional nature of the study provided infor-
mation on the association between ambulatory PA and
clinical outcomes. No causal inference could therefore
be drawn.
The study was limited to those employees attending
the health screening event and/or willing to participate
in the study. This presents a selection bias, as the group
agreeing to participate may be different from the non-
participating employees. We were also not able to obtain
data on the response rate of those invited to participate,
and those that were excluded in the analysis.
Pedometers measure ambulatory PA. Our study was,
therefore, limited to participants performing activities
more specific to ambulation and did not include activ-
ities such as swimming, cycling and weight training.
The low steps/day volume noted in our study (6,574 +
3,541) may be related to the paucity of the data obtained
(i.e. three consecutive days of pedometer-wear, mini-
mum wear-time of ten hours). The wearing time is in
keeping with documented literature that make reference
to such criteria as a reasonable estimate of daily ambula-
tory PA [51,28,29].
The categorization of manufacturer-defined “aerobic”
steps, from the hourly display into a more representative
estimate of moderate intensity PA (i.e. 100 steps/minute in
bouts of at least ten minutes), can be seen as a limitation
due to the manual method by which this re-categorization
of the data was performed.
Consequently, the sub-grouping of the data according
to intensity-based categories using 21 minutes/day of
Pillay et al. BMC Public Health  (2015) 15:174 Page 11 of 12aerobic activity, as a proxy for current PA guidelines,
may be viewed as a further limitation, as this sub-
grouping is similarly based on the manual tallying of
data. This criterion has, however, allowed us to provide
some level of differentiation of PA according to total vol-
ume of steps/day and aerobic time.
Conclusions
The findings of this research highlight the effect of vol-
ume and intensity of steps/day on health outcomes. The
mediation effect of typical measures of body compos-
ition on the association between daily steps and health
outcomes is also demonstrated. This mediation effect
highlights the importance of PA in improving health by
improving body composition.
The study adds to current documented literature in pro-
viding some information on intensity-based steps/day in a
cross-sectional study. Our study additionally provides a
unique application of steps/minute recommendations to
our data. In so doing, our findings relate closely to current
PA guidelines by adopting an appropriate estimate of
moderate intensity PA, as part of our criterion in the data
analyses. The consequent integration of volume, intensity
and duration of ambulatory PA in pedometer-based guide-
lines, is of emerging relevance as an option for meeting
current guidelines.
The mediation analysis, in highlighting that body com-
position completely mediates the association between
physical activity and health outcomes, provides an inter-
esting and unique observation that may have far-reaching
implications on PA and health.
Further studies using a similar but broader approach
can be adopted so as to provide prevalence data rather
than data through convenience sampling.
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